Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alzchem Group AGXTER:ACT +0.29%60 Earnings Yield (Joel Greenblatt) % is 5.93% as of Mar. 2026, which is 56% below its 10-year median of 13.51. GuruFocus rates XTER:ACT with a GF Score™ of 60/100. The stock has 4 warning signs investors should review. Among 1,627 Chemicals companies, Alzchem Group AG ranks better than 61.83% on this metric.
Alzchem Group AG's Enterprise Value for the quarter that ended in Mar. 2026 was €1,651.7 Mil.
Alzchem Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €97.5 Mil. Alzchem Group AG's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 5.93%.
The historical rank and industry rank for Alzchem Group AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XTER:ACT'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.1 Med: 13.51 Max: 314.54
Current: 5.68
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Alzchem Group AG was 314.54%. The lowest was 2.10%. And the median was 13.51%.
XTER:ACT's Earnings Yield (Joel Greenblatt) % is ranked better than 61.83% of 1627
companies
in the Chemicals industry
Industry Median: 3.68
vs XTER:ACT: 5.68
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Alzchem Group AG's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 21.72%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Alzchem Group AG (XTER:ACT) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Alzchem Group AG Earnings Yield (Joel Greenblatt) % Related Terms
Alzchem Group AG Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Alzchem Group AG's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzchem Group AG Earnings Yield (Joel Greenblatt) % Chart
For the Specialty Chemicals subindustry, Alzchem Group AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG Earnings Yield (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's Earnings Yield (Joel Greenblatt) % falls into.
Alzchem Group AG Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Alzchem Group AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Alzchem Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €97.5 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 5.93% mean?
Alzchem Group AG (XTER:ACT) has a Earnings Yield (Joel Greenblatt) % of 5.93% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Alzchem Group AG and its competitors. This is 56% below median its historical median of 13.51. Over the past decade, Alzchem Group AG's Earnings Yield (Joel Greenblatt) % has ranged from 2.10 to 314.54. According to the industry distribution chart, Alzchem Group AG ranks #621 out of 1627 companies in the Chemicals industry, placing it in the top 38.2%.
Is Alzchem Group AG's Earnings Yield (Joel Greenblatt) % too high?
Alzchem Group AG's current Earnings Yield (Joel Greenblatt) % of 5.93% is 56% below median its 10-year median of 13.51. Over the past 10 years, this metric has ranged from a low of 2.10 to a high of 314.54. The Chemicals industry median Earnings Yield (Joel Greenblatt) % is 3.68. Alzchem Group AG's value of 5.93% is 61.1% above this industry median. Based on the distribution chart, Alzchem Group AG ranks #621 out of 1627 companies in the Chemicals industry, which is above the industry midpoint. Overall, Alzchem Group AG has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Earnings Yield (Joel Greenblatt) % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #621 out of 1627 companies for Earnings Yield (Joel Greenblatt) %. This puts Alzchem Group AG in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.68. Alzchem Group AG's value of 5.93% is 61.1% above this benchmark. Historically, Alzchem Group AG's own Earnings Yield (Joel Greenblatt) % has ranged from 2.10 to 314.54 over the past decade. While the company's 10-year median is 13.51 vs. the industry median of 3.68, Alzchem Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Chemicals company?
The median Earnings Yield (Joel Greenblatt) % among Chemicals companies is 3.68, based on 1,627 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alzchem Group AG's current Earnings Yield (Joel Greenblatt) % of 5.93% is 61.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Alzchem Group AG and its competitors. For the Chemicals industry, the median Earnings Yield (Joel Greenblatt) % is 3.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzchem Group AG's current Earnings Yield (Joel Greenblatt) % is 5.93%, which is 56% below median its own 10-year median of 13.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current Earnings Yield (Joel Greenblatt) % of 5.93%. The current Earnings Yield (Joel Greenblatt) % is 5.93%, which is 56% below median its 10-year median of 13.51 and 61.1% above the Chemicals industry median of 3.68. Alzchem Group AG's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Earnings Yield (Joel Greenblatt) % is 5.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
60GF Score
Get the complete analysis for XTER:ACT
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:ACT has been successfully added to your 
